IPO Watch

Specialty GI play Ventrus Biosciences Inc. filed to raise up to $19.6 million in an IPO through underwriter National Securities.

Since its inception in 2005, the company has been funded through $10.6 million in convertible notes; $1.5 million in non-convertible notes; and less than $1 million in equity financing...